Avidity Biosciences: Revolutionizing RNA Therapeutics Field (NASDAQ:RNA)
nambitomo/iStock via Getty Images Avidity Biosciences (NASDAQ:RNA) is a small (volatile and currently below $1 billion market cap) biopharmaceutical company focusing on RNA therapeutics, On Dec. 14, the Avidity announced positive preliminary data from MARINA, […]
